Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target.

PloS one - 1 Jan 2014

Fatima Kaneez, Mathew Shilu, Suhail Mohd, Ali Ashraf, Damanhouri Ghazi, Azhar Esam, Qadri Ishtiaq

Abstract excerpt

The nonstructural protein 3 (NS3) of hepatitis C virus (HCV) helicase is believed to be essential for viral replication and has become an attractive target for the development of antiviral drugs. The study of helicase is useful for elucidating its involvement in positive sense single-stranded RNA virus replication and to serve as templates for the design of novel antiviral drugs. In recent years, several models...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Aptamers, Nucleotide
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Protein Structure, Tertiary

Share to RNA, Viral

Share to Viral Nonstructural Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 25188400
DOI: 10.1371/journal.pone.0106339
PMCID: PMC4154687

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target.PMID 25188400Read ↗

Mechanistic insights into Zika virus NS3 helicase inhibition by Epigallocatechin-3-gallateSemantic proximity Read ↗

Helicase Inhibitors as Specifically Targeted Antiviral Therapy for Hepatitis cSemantic proximity Read ↗

Rational drug discovery: Ellagic acid as a potent dual-target inhibitor against hepatitis C virus genotype 3 (HCV G3) NS3 enzymes.Semantic proximity Read ↗

A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicaseSemantic proximity Read ↗

Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.Semantic proximity Read ↗

Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization.Semantic proximity Read ↗

Structure-activity relationships of fluorene compounds inhibiting HCV variants.Semantic proximity Read ↗

Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.Semantic proximity Read ↗

Molecular docking investigation of the binding interactions of macrocyclic inhibitors with HCV NS3 protease and its mutants (R155K, D168A and A156V).Semantic proximity Read ↗

Applications of computer-aided approaches in the development of hepatitis C antiviral agentsSemantic proximity Read ↗

Mutational analyses, pharmacophore-based inhibitor design and in silico validation for Zika virus NS3-helicase.Semantic proximity Read ↗

Development of robust in vitro serine protease assay based on recombinant Pakistani HCV NS3-4A protease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.